Skip to main content

Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

White Paper

Semaglutide - Dr. Reddy’s Fully Synthetic Peptide API

Chemical Structure of Semaglutide

Semaglutide is a glucagon-like peptide 1 (GLP-1) receptor agonist, with 94% sequence homology to human GLP-1 indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus.

In this whitepaper, we look at Dr. Reddy’s Semaglutide, a synthetic peptide identical to the innovator molecules. As the innovator molecule and unlike most generic versions in the market, it is neither a base addition salt (Sodium, Potassium, and the likes) nor an acid addition salt (Acetate, Trifluoroacetate, Hydrochloride, and the likes).

Dr. Reddy’s provides a unique end-to-end product offering where customers can choose from the following business models:

  • API purchase
  • API + device purchase
  • Combination of API and Salcaprozpate sodium (SNAC) for oral formulation
  • Finished formulations purchase

To know more about our API offerings, please read the White paper on Semaglutide by filling the contact from below.

Explore other Whitepapers:

Know More

Download Now

Please fill the Contact form below in order to view the white paper

Checked out our

API Linkedin
page yet?

Follow this page to explore how our offerings can accelerate your formulation success

Click here to visit